1) Extended Field of View vs. Standard Field of View 18F fluoro-2-deoxy-glucose PET/CT Imaging for Melanoma; 2) The Diagnostic Accuracy of 68Ga-PSMA PET/CT versus 99mTc-MDP Bone Scintigraphy for Identifying Bone Metastases in persons with Prostate Cancer

1) Extended Field of View vs. Standard Field of View 18F fluoro-2-deoxy-glucose PET/CT Imaging for Melanoma; 2) The Diagnostic Accuracy of 68Ga-PSMA PET/CT versus 99mTc-MDP Bone Scintigraphy for Identifying Bone Metastases in persons with Prostate Cancer

No continuing education credits

1) Extended Field of View vs. Standard Field of View 18F fluoro-2-deoxy-glucose PET/CT Imaging in Melanoma Patients

Presenter: Nichole Bower

Learning Objectives:
– Advance knowledge of the role of PET/CT in the clinical management of cutaneous melanoma.
– Enhance the understanding of image appropriateness in PET/CT for melanoma based on research findings.
– Identify barriers and facilitators of MRT led research.

2) The Diagnostic Accuracy of 68Ga-PSMA PET/CT versus 99mTc-MDP Bone Scintigraphy for Identifying Bone Metastases in persons with Prostate Cancer: A Systematic Review

Presenter: Lisa Bonin

Learning Objectives:
– Gain perspective on the processes and challenges associated with performing a systematic literature review.
– Appreciate the merits of 99mTc-MDP planar bone scintigraphy and 68Ga PSMA PET-CT in evaluating skeletal metastases in prostate cancer patients.
– Discern between measures of imaging accuracy in detection of bone metastases in prostate cancer patients for the radiopharmaceuticals discussed, and consider future best practices.